TARA BEIGHTOL: Open Payments
NPI 1578542056 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$895 in 33 payments from 15 companies in 2025. Trend: 2023 $755 · 2024 $832 · 2025 $895
Food & beverage: $845Long term medical supply or device loan: $50
| Company | Payments | Amount |
|---|---|---|
| Sequel Med Tech, LLC | 2 | $229 |
| AstraZeneca Pharmaceuticals LP | 6 | $138 |
| Novo Nordisk Inc | 4 | $99 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| Abbott Laboratories | 2 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $64 |
| ABBVIE INC. | 2 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $18 |
Products named: TWIIST, AIRSUPRA, SHINGRIX, JARDIANCE, QULIPTA, FREESTYLE INSULINX, FARXIGA, Rybelsus.
Industry payments across TN — which companies pay providers there.
